Author Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial

Nature Medicine issued an author correction to its article on toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma, described as a multicenter randomized phase 3 trial. The feed provides no details about the correction's content, so no findings can be summarized.

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.